Arca Biopharma sell StockNews.com
Start price
25.03.23
/
50%
€1.84
Target price
25.03.24
-
Performance (%)
-14.49%
End price
26.03.24
€1.57
Summary
This prediction ended on 26.03.24 with a price of €1.57. The price of Arca Biopharma decreased from the start of the prediction. Compared to the start price this resulted in a performance of -14.49%. StockNews_com has a follow-up prediction for Arca Biopharma where he still thinks Arca Biopharma is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arca Biopharma | 2.516% | 2.516% | 75.741% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat
In the thread Trading Arca Biopharma
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten